Heart failure with preserved ejection fraction

There are 791 papers on heart failure with preserved ejection fraction in aging research: 70 trials and 316 observational studies in people, 80 in animals, 1 in cells, 312 reviews. The newest story, Nov 17, 2026: “Fine-particle pollution linked to heart failure types in China”.

Disease

791 papers study it102 more mention it172 findings

175 new papers in 30 daysSee all 894 papers on heart failure with preserved ejection fraction

“the change over time differed significantly between HF types (p for time*HF type=0.005), with a greater improvement observed in HFpEF.”
Impact of different exercise training modalities on patient-reported outcomes in heart failure with reduced and preserved ejection fractionESC Congress 2026 abstract2026doi:10.1093/eurheartj/ehag785.3637
  • Human trial70
  • Humans316
  • Animals80
  • Cells1
  • In silico5

Interventions

16

Exercise

downin humans1downin pigs1

2 studies
  1. Exercise prevents heart failure with preserved ejection fraction in pigs under progressive LVPO.

    “a concomitant exercise protocol overlayed with a progressive LVPO stimulus prevented the HFpEF phenotype”

    Animalsunder progressive LVPO5 wkn = 8

    Modifying the structural substrate and progression of heart failure with preserved ejection fraction using a regular exercise regimen in pigs

    American journal of physiology. Heart and circulatory physiology

  2. Exercise protects against heart failure with preserved ejection fraction in humans (cardiac ageing and HFpEF).

    “The protective and mitigating effects of exercise in cardiac ageing and HFpEF in particular are discussed”

    Reviewcardiac ageing and HFpEF

    Cardiac ageing: from hallmarks to therapeutic opportunities

    Cardiovascular research

More on Exercise

Cardiometabolic stress

upin mice1

1 study
  1. Cardiometabolic stress induces heart failure with preserved ejection fraction in mice (two-hit protocol).

    “Unlike young female mice, aged mice developed HFpEF, coinciding with impaired cardiac mitochondrial function and disrupted mitochondrial proteostasis.”

    Animalstwo-hit protocolheartfemales

    Older female mice developed heart failure under combined stress

    Journal of molecular and cellular cardiology

More on Cardiometabolic stress

SGLT2 inhibitors

downin humans1

1 study
  1. SGLT2 inhibitors decrease heart failure with preserved ejection fraction in humans (independent of diabetes status).

    “SGLT2i, exemplified by empagliflozin, demonstrated foundational benefit through natriuresis, improved myocardial energetics and reduced heart failure hospitalization independent of diabetes status”

    Reviewindependent of diabetes status

    Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era

    Endocrinology, diabetes & metabolism

More on SGLT2 inhibitors

Ganciclovir

downin mice1

1 study
  1. Ganciclovir decreases heart failure with preserved ejection fraction in mice (p16-3MR mice subjected to four-hit cardiovascular-kidney-metabolic stress).

    “Selective genetic ablation of p16+ senescent cells using ganciclovir ameliorated HFpEF phenotypes”

    Animalsp16-3MR mice subjected to four-hit cardiovascular-kidney-metabolic stressheart

    Senescence and DNA Damage-Induced Inflammation Drive Heart Failure with Preserved Ejection Fraction in Cardiovascular Kidney Metabolic Syndrome

    bioRxiv : the preprint server for biologyPreprint

More on Ganciclovir

AAV-ULK1 gene therapy

downin mice1

1 study
  1. AAV-ULK1 gene therapy decreases heart failure with preserved ejection fraction in mice with HFpEF.

    “ULK1 overexpression via AAV-9 attenuated the HFpEF phenotype in mice.”

    Animalsin mice with HFpEFheartmales

    Small extracellular vesicle-mediated adipocyte-cardiomyocyte crosstalk exacerbates heart failure with preserved ejection fraction

    Cardiovascular research

More on AAV-ULK1 gene therapy

Rapamycin

downin mice1

1 study
  1. Rapamycin decreases heart failure with preserved ejection fraction in mice with HFpEF.

    “Restoration of cardiac autophagy with rapamycin or ULK1 overexpression via AAV-9 attenuated the HFpEF phenotype in mice.”

    Animalsin mice with HFpEFheartmales

    Small extracellular vesicle-mediated adipocyte-cardiomyocyte crosstalk exacerbates heart failure with preserved ejection fraction

    Cardiovascular research

More on Rapamycin

miR-295-3P antagomir

downin mice1

1 study
  1. miR-295-3P antagomir decreases heart failure with preserved ejection fraction in HFpEF mice.

    “MiR-295-3p antagomir treatment mitigated HFpEF phenotypes.”

    Animalsin HFpEF miceheartmales

    Small extracellular vesicle-mediated adipocyte-cardiomyocyte crosstalk exacerbates heart failure with preserved ejection fraction

    Cardiovascular research

More on miR-295-3P antagomir

Visceral adipose tissue resection

downin mice1

1 study
  1. Visceral adipose tissue resection decreases heart failure with preserved ejection fraction in HFpEF mice.

    “Resection or transplantation of visceral adipose tissue (VAT) blunted or exacerbated HFpEF phenotypes, respectively, in mice.”

    Animalsin HFpEF miceheartmales

    Small extracellular vesicle-mediated adipocyte-cardiomyocyte crosstalk exacerbates heart failure with preserved ejection fraction

    Cardiovascular research

More on Visceral adipose tissue resection

Alcohol

no changein humans1HR 1.05

1 study
  1. Alcohol was not clearly linked with heart failure with preserved ejection fraction in humans (Heavy drinkers compared with never drinkers) (HR 1.05, 95% CI 0.96–1.13).

    “heavy drinking was significantly associated with HFrEF (HR: 1.13, 95% CI: 1.02, 1.24), not HFpEF (HR: 1.05, 95% CI: 0.96, 1.13).”

    HumansHeavy drinkers compared with never drinkers>4 drinks/day and/or diagnosed with alcohol use disorderMean follow-up of 6.4 years91% mensn = 401,348

    Alcohol Intake and Incidence of Heart Failure and Its Subtypes: VA Million Veteran Program

    Nutrients

More on Alcohol

Estrogen

downin mice1

1 study
  1. Estrogen protects against heart failure with preserved ejection fraction in WT female mice.

    “OVX in WT females validated the importance of estrogen for HFpEF resistance.”

    Animalsin WT female micefemales

    Sex-specific cardioprotective role of miR-30a-5p through estrogen-dependent mechanisms in a mouse model of heart failure

    Cardiovascular diabetology

More on Estrogen

All 16

Effects

14

Mitochondrial biogenesis (PGC-1α)

no changein mice1

1 study
  1. Heart failure with preserved ejection fraction showed no clear effect on mitochondrial biogenesis (PGC-1α) in 3-hit HFpEF model.

    “In contrast, key regulators of mitochondrial biogenesis were preserved.”

    Animalsin 3-hit HFpEF modelcardiomyocytes

    Mitochondrial proteostasis is impaired in mouse heart failure

    American journal of physiology. Heart and circulatory physiology

More on Mitochondrial biogenesis (PGC-1α)

Proteostasis

downin mice1

1 study
  1. Heart failure with preserved ejection fraction impairs proteostasis in 3-hit HFpEF model.

    “mitochondrial chaperones and proteases for protein quality control were reduced, leading to increased accumulation of ubiquitinated mitochondrial proteins and impaired mitochondrial proteostasis.”

    Animalsin 3-hit HFpEF modelcardiomyocyte mitochondria

    Mitochondrial proteostasis is impaired in mouse heart failure

    American journal of physiology. Heart and circulatory physiology

More on Proteostasis

Mitochondrial respiratory capacity

downin mice1

1 study
  1. Heart failure with preserved ejection fraction decreases mitochondrial respiratory capacity in mice (high-fat diet and L-NAME).

    “mitochondrial respiratory capacity measured by high-resolution respirometry (Oroboros) was significantly reduced in left ventricular muscle fibers.”

    Animalshigh-fat diet and L-NAMEleft ventricular muscle fibers

    Mitochondrial proteostasis is impaired in mouse heart failure

    American journal of physiology. Heart and circulatory physiology

Mortality

upin humans1

1 study
  1. Heart failure with preserved ejection fraction increases mortality in patients with CKD.

    “Heart failure with preserved ejection fraction (HFpEF) contributes to significant morbidity and mortality among patients with CKD.”

    Reviewin patients with CKD

    The Intersection of Heart Failure with Preserved Ejection Fraction and CKD

    Clinical journal of the American Society of Nephrology : CJASN

Peak descending aortic circumferential strain

downin humans1

1 study
  1. Heart failure with preserved ejection fraction is linked with lower peak descending aortic circumferential strain in humans (heart failure with preserved ejection fraction) (3.8% ± 1.6% vs 11.4% ± 2.2%, P < 0.02).

    “Peak descending aortic strain (young: 11.4% ± 2.2%; older: 4.8% ± 1.6%; HFpEF 3.8% ± 1.6%) and absolute distension were lower (all, P < 0.02) in the older and HFpEF groups compared to the young.”

    Humansheart failure with preserved ejection fraction

    Circumferential strain and strain rates of the descending aorta as novel measures of aortic stiffness and wall mechanics from standard cardiac MRI

    Experimental physiology

More on Peak descending aortic circumferential strain

STAT3

downin mice1

1 study
  1. Heart failure with preserved ejection fraction decreases STAT3 in HFpEF.

    “we identified reduced STAT3 expression as a hallmark of HFpEF pericytes”

    Animalsin HFpEFcardiac pericytes

    STAT3 expression is reduced in cardiac pericytes in HFpEF and its loss reduces cellular adhesion and induces pericyte senescence

    FEBS letters

More on STAT3

Balance confidence

downin humans1

1 study
  1. Heart failure with preserved ejection fraction is linked with lower balance confidence in patients with HFpEF vs healthy controls (-21.5%, p < 0.05).

    “lower balance confidence by 21.5% (p < 0.05)”

    Humansin patients with HFpEF vs healthy controls

    Assessing Static Balance, Balance Confidence, and Fall Rate in Patients with Heart Failure and Preserved Ejection Fraction: A Comprehensive Analysis

    Sensors (Basel, Switzerland)

Static balance

downin humans1

1 study
  1. Heart failure with preserved ejection fraction is linked with worse static balance in patients with HFpEF vs healthy controls (p < 0.05).

    “Patients with HFpEF presented with lower static balance in BS and TRS compared to healthy controls (p < 0.05)”

    Humansin patients with HFpEF vs healthy controls

    Assessing Static Balance, Balance Confidence, and Fall Rate in Patients with Heart Failure and Preserved Ejection Fraction: A Comprehensive Analysis

    Sensors (Basel, Switzerland)

Myofiber growth

downin rats1

1 study
  1. Heart failure with preserved ejection fraction impairs myofiber growth in HFpEF following resistance exercise.

    “low myofiber growth in HFpEF following resistance exercise”

    Animalsin HFpEF following resistance exercise

    Caloric Restriction Rejuvenates Skeletal Muscle Growth in Heart Failure With Preserved Ejection Fraction

    JACC. Basic to translational science

myonuclear accretion

downin rats1

1 study
  1. Heart failure with preserved ejection fraction impairs myonuclear accretion in HFpEF following resistance exercise.

    “we identified impaired myonuclear accretion as a mechanism for low myofiber growth in HFpEF following resistance exercise”

    Animalsin HFpEF following resistance exercise

    Caloric Restriction Rejuvenates Skeletal Muscle Growth in Heart Failure With Preserved Ejection Fraction

    JACC. Basic to translational science

All 14

Upstream

10

Weight loss

downin humans1

1 study
  1. weight loss decreases heart failure with preserved ejection fraction in humans.

    “Although robust trial evidence supports weight loss as a disease-modifying strategy in some conditions, including but not limited to type 2 diabetes and heart failure with preserved ejection fraction”

    Review

    From adiposity to multisystem morbidity: the case for weight loss as disease modification

    The lancet. Diabetes & endocrinology

SUB1

upin mice1

1 study
  1. SUB1 increases heart failure with preserved ejection fraction in mice.

    “Sub1 knockdown delays cardiac aging and alleviates HFpEF features, even when initiated in aged mice.”

    Animals

    Sub1 contributes to heart failure with preserved ejection fraction driven by aging in mice

    Nature communications

More on SUB1

Inflammation

mediatesin reviews1

1 study
  1. Inflammation mediates heart failure with preserved ejection fraction.

    “heart failure with a preserved ejection fraction (HFpEF) results from an inflammatory process, congestion, and metabolic dysbiosis”

    Review

    Heart failure with preserved ejection fraction beyond the heart: exploring the heart-liver-pancreas axis

    ESC heart failure

More on Inflammation

LGALS1

no changein mice1

1 study
  1. LGALS1 showed no clear effect on heart failure with preserved ejection fraction in DOCA-salt-induced HFpEF mouse model.

    “Mice with myeloid cell or global deficiency of galectin-1, however, exhibit no difference in deoxycorticosterone acetate-salt-induced HFpEF.”

    Animalsin DOCA-salt-induced HFpEF mouse model

    Galectin-1 Is a Marker but Not a Mediator of Heart Failure With Preserved Ejection Fraction

    Hypertension (Dallas, Tex. : 1979)

More on LGALS1

MIR30A

downin mice1

1 study
  1. MIR30A protects against heart failure with preserved ejection fraction in mice (24-week HFD/L-NAME).

    “Female KO mice lost the inherent resistance of WT females to HFpEF induction via 24-week HFD/L-NAME”

    Animals24-week HFD/L-NAME24 weeksfemales

    Sex-specific cardioprotective role of miR-30a-5p through estrogen-dependent mechanisms in a mouse model of heart failure

    Cardiovascular diabetology

More on MIR30A

Adiponectin

no changein humans1

1 study
  1. Adiponectin was not clearly linked with heart failure with preserved ejection fraction in humans after adjusting for NT-proBNP.

    “There was no significant association between adiponectin and heart failure with preserved ejection fraction after adjusting for NT-proBNP.”

    Humansafter adjusting for NT-proBNP

    Does Adiponectin Inform Cardiovascular Risk in Older Adults?: The ARIC Study

    JACC. Advances

More on Adiponectin

mTOR signaling

upin mice1

1 study
  1. mTOR signaling increases heart failure with preserved ejection fraction in mice (shown by cardiac-specific mTORC1 inhibition).

    “cardiac-specific mTORC1 inhibition protects against HFpEF”

    Animalsshown by cardiac-specific mTORC1 inhibitionheart

    Proteostatic Imbalance Drives the Pathogenesis and Age-Related Exacerbation of Heart Failure With Preserved Ejection Fraction

    JACC. Basic to translational science

More on mTOR signaling

Race and gender

no changein humans1

1 study
  1. race and gender was not clearly linked with heart failure with preserved ejection fraction in humans (adjusted for cardiovascular comorbidities).

    “No race/gender-based differences were observed in risk of incident heart failure with preserved ejection fraction.”

    Humansadjusted for cardiovascular comorbiditiesn = 5,149

    Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure

    Journal of the American College of Cardiology

MIR29A

downin mice1

1 study
  1. MIR29A protects against heart failure with preserved ejection fraction in mice (shown by knockout).

    “mice deficient in miR-29a/b1 develop vascular remodeling and systemic hypertension, as well as HF with preserved ejection fraction (HFpEF)”

    Animalsshown by knockoutheart

    The microRNA-29/PGC1α regulatory axis is critical for metabolic control of cardiac function

    PLoS biology

More on MIR29A

Carotid-femoral pulse wave velocity

no changein humans1HR 1.06

1 study
  1. Carotid-femoral pulse wave velocity was not clearly linked with heart failure with preserved ejection fraction in humans after adjustment for potential confounders (HR 1.06 (95% CI 0.72-1.56)).

    “cf-PWV velocity was also not associated with risk of HFpEF and HFrEF after adjustment for potential confounders”

    Humansafter adjustment for potential confoundersn = 2,290

    Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition)

    Hypertension (Dallas, Tex. : 1979)

More on Carotid-femoral pulse wave velocity

Associations

109

Female sex

upin humans4

4 studies
  1. Female sex is associated with heart failure with preserved ejection fraction in humans (HF cases).

    “HFpEF was the more prevalent subtype among older women.”

    HumansHF casesfemales

    Heart failure clinical care analysis uncovers risk reduction opportunities for preserved ejection fraction subtype

    Scientific reports

  2. Female sex is associated with heart failure with preserved ejection fraction in humans.

    “women have a higher incidence of heart failure with preserved ejection fraction”

    Reviewfemales

    Sex Differences in Cardiovascular Aging

    Nursing Edição Brasileira

  3. female sex raises the risk of heart failure with preserved ejection fraction in humans (nearly double).

    “Women have a nearly double lifetime risk of developing HFpEF compared to heart failure with reduced ejection fraction (HFrEF).”

    Reviewfemales

    Underpinnings of heart failure with preserved ejection fraction in women - From prevention to improving function. A co-publication with the American Journal of Preventive Cardiology and the Journal of Cardiac Failure

    American journal of preventive cardiology

  4. Female sex is associated with heart failure with preserved ejection fraction in humans (heart failure).

    “Compared with men, women tend to develop HF later in life and are more likely to experience HF with preserved ejection fraction.”

    Reviewheart failurefemale versus males

    A disease of her own? Unique features of heart failure in women

    Climacteric : the journal of the International Menopause Society

Cellular senescence

upin humans1mixedin reviews1upin reviews1

3 studies
  1. Cellular senescence is associated with heart failure with preserved ejection fraction.

    “much of the current evidence linking senescence to HFpEF remains preclinical or associative, and HFpEF-specific human data are still limited.”

    Review

    Cellular Senescence in Heart Failure with Preserved Ejection Fraction: Mechanisms and Therapeutic Opportunities

    Ageing research reviews

  2. Cellular senescence raises the risk of heart failure with preserved ejection fraction.

    “Cellular senescence and the ensuing senescence-associated secretory phenotype (SASP) significantly contribute to the pathogenesis and progression of HFpEF.”

    Review

    Cellular Senescence and the SASP in HFpEF: Pathogenic Mechanisms and Therapeutic Targeting

    International journal of molecular sciences

  3. Heart failure with preserved ejection fraction is associated with cellular senescence in HFpEF.

    “EC and cardiomyocyte cell senescence has been reported during HFpEF”

    Reviewin HFpEF

    A potential role of autophagy-mediated vascular senescence in the pathophysiology of HFpEF

    Frontiers in endocrinology

More on Cellular senescence

Obesity

upin humans2upin reviews1

3 studies
  1. Heart failure with preserved ejection fraction is associated with obesity in humans (suspected HFpEF in primary care).

    “Patients with HFpEF were more likely to be obese, pre-frail or frail, report more dyspnoea and fatigue, were more functionally impaired, and less active than patients in whom HFpEF was refuted.”

    Humanssuspected HFpEF in primary caren = 152

    Characteristics of patients with heart failure with preserved ejection fraction in primary care: a cross-sectional analysis

    BJGP open

  2. Obesity is associated with heart failure with preserved ejection fraction.

    “Obesity in women is linked to hyperinsulinemia, hyperandrogenism, chronic inflammation, impaired ovulation, infertility, visceral and epicardial adiposity, and obesity-related HFpEF.”

    Reviewfemales

    Impact of Obesity in Women Health and Approach to Optimize Obesity Care with Glucagon-like Peptide-1 Receptor Agonist

    International Journal of Diabetes and Technology

  3. Obesity raises the risk of heart failure with preserved ejection fraction in humans.

    “Obesity may also lead to heart failure with preserved ejection fraction in middle-aged persons, especially in African American women.”

    Review

    Weight Reduction for Obesity-Induced Heart Failure with Preserved Ejection Fraction

    Current hypertension reports

More on Obesity

Mortality

upin humans3HR 1.32

3 studies
  1. Heart failure with preserved ejection fraction is linked with a higher risk of mortality in humans (at 48 months, compared to non-HFpEF patients (4.6% all-cause, 1.5% cardiovascular)) (all-cause mortality 12.3% vs 4.6%, cardiovascular mortality 5.9% vs 1.5%, P < 0.05).

    “At 48 months, cumulative all-cause mortality was 18.9%, 12.3%, and 4.6%, respectively, and cardiovascular mortality was 10.8%, 5.9%, and 1.5% (log-rank P < 0.05).”

    Humansat 48 months, compared to non-HFpEF patients (4.6% all-cause, 1.5% cardiovascular)48 months

    Large language model detects previously undiagnosed heart failure with preserved ejection fraction in patients with metabolic-associated fatty liver disease: A multicenter cohort study

    PLOS digital health

  2. Heart failure with preserved ejection fraction is linked with a higher risk of mortality in humans (HFpEF patients vs age- and gender-matched general population) (SMR 3.37, 95% CI: 2.4-4.7).

    “HFpEF patients < 80 years had a three times higher mortality risk (SMR 3.37, 95% CI: 2.4-4.7)”

    HumansHFpEF patients vs age- and gender-matched general population

    Heart failure with preserved ejection fraction shows no excess mortality in older patients: a population-matched relative survival analysis

    GeroScience

  3. Heart failure with preserved ejection fraction is associated with mortality in heart failure patients (HR 1.32, CI 1.08-1.61).

    “Heart failure with preserved ejection fraction (HFpEF) was associated with a 32% (HR 1.32, CI 1.08-1.61, P = 0.007) higher mortality compared to HFrEF.”

    Humansin heart failure patients

    The association between polypharmacy and mortality in patients with heart failure: Results from the PULSE dataset

    ESC heart failure

Metabolic dysfunction-associated steatotic liver disease

upin humans1mixedin humans1upin reviews1

3 studies
  1. Metabolic dysfunction-associated steatotic liver disease is associated with heart failure with preserved ejection fraction in humans.

    “dynamic, bidirectional inter-organ crosstalk between the liver and the heart that shapes their natural history”

    Review

    HFpEF and MASLD: converging mechanisms and clinical implications

    Nature reviews. Cardiology

  2. Metabolic dysfunction-associated steatotic liver disease is associated with heart failure with preserved ejection fraction in humans.

    “Shared risk factors and inflammatory pathways have highlighted a strong bidirectional association between MASLD and cardiovascular diseases, particularly HFpEF.”

    Review

    Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review

    World journal of cardiology

  3. Metabolic dysfunction-associated steatotic liver disease is associated with heart failure with preserved ejection fraction.

    “Simultaneously, patients with NAFLD or NASH commonly show diastolic dysfunction or latent HFpEF.”

    Review

    Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease

    The American journal of medicine

More on Metabolic dysfunction-associated steatotic liver disease

Frailty

upin humans3

3 studies
  1. Heart failure with preserved ejection fraction is associated with frailty in humans (heart failure) (55.2% vs. 46.8%, P = 0.043).

    “The proportions of patients with physical frailty were 55.2% in HFpEF patients and 46.8% in HFrEF patients, and the proportion was significantly higher in HFpEF patients (P = 0.043).”

    Humansheart failuren = 645

    Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction

    ESC heart failure

  2. Heart failure with preserved ejection fraction is associated with frailty in humans (suspected HFpEF in primary care).

    “Patients with HFpEF were more likely to be obese, pre-frail or frail, report more dyspnoea and fatigue, were more functionally impaired, and less active than patients in whom HFpEF was refuted.”

    Humanssuspected HFpEF in primary caren = 152

    Characteristics of patients with heart failure with preserved ejection fraction in primary care: a cross-sectional analysis

    BJGP open

  3. Heart failure with preserved ejection fraction raises the risk of frailty in humans.

    “HFpEF and frailty share common underlying mechanisms, often co-exist, and represent each other's risk factors.”

    Review

    Heart Failure With Preserved Ejection Fraction and Frailty: From Young to Superaged Coexisting HFpEF and Frailty

    International journal of heart failure

Ultra-processed foods

upin humans2HR 1.096–1.11

2 studies
  1. Ultra-processed foods are associated with heart failure with preserved ejection fraction in humans (without cardiovascular disease at baseline) (HR 1.096, 95% CI 1.016–1.183; upper 80% versus lowest 20%: HR 2.234, 95% CI 1.289–3.874).

    “UPF intake remained significantly associated with HFpEF (HR 1.096; 95% CI 1.016–1.183), but not HFrEF.”

    Humanswithout cardiovascular disease at baseline

    Ultra-processed foods linked to heart failure in US adults

    JACC. Heart failure

  2. Ultra-processed foods are associated with heart failure with preserved ejection fraction in humans (phenotype-stratified analysis) (HR 1.11; 95% CI 1.02-1.19).

    “When stratified by phenotype, UPF intake remained significantly associated with HFpEF (HR 1.11; 95% CI 1.02-1.19), but not HFrEF/HFmrEF.”

    Humansphenotype-stratified analysis

    Ultra-processed foods linked to higher heart failure risk

    AHA Scientific Sessions 2026 abstract

More on Ultra-processed foods

TET2

upin humans2HR 2.5

2 studies
  1. TET2 is linked with a higher risk of heart failure with preserved ejection fraction in humans (aHR 1.40 (95% CI: 1.03-1.90)).

    “TET2 CHIP was associated with HFpEF (aHR: 1.40 [95% CI: 1.03-1.90]; P = 0.03)”

    Humansmedian follow-up 10.1 yearsfemalesn = 6,677

    Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women

    Journal of the American College of Cardiology

  2. TET2 is associated with heart failure with preserved ejection fraction in humans (TET2 mutation carriers) (HR 2.50, 95% CI 1.54–4.06).

    “TET2 strongly drives incident HF with preserved ejection fraction (HR=2.50, 95%CI 1.54-4.06)”

    ReviewTET2 mutation carriers

    Clonal Hematopoiesis of Indeterminate Potential as a Cardiovascular Driver - An Umbrella Review of Systematic Reviews and Meta-Analyses

    AHA Scientific Sessions 2026 abstract

More on TET2

Clonal hematopoiesis of indeterminate potential

upin humans2

2 studies
  1. Clonal hematopoiesis of indeterminate potential is associated with heart failure with preserved ejection fraction in humans (patients undergoing treatment for solid tumors).

    “Patients with CHIP were more likely to have coronary artery disease (CAD) (p-value <0.001) and HFpEF (p-value 0.007)”

    Humanspatients undergoing treatment for solid tumorsheartn = 236

    Clonal hematopoiesis of indeterminate potential (CHIP) is associated with increased risk of diastolic dysfunction in a cardio-oncology cohort

    ESC Congress 2026 abstract

  2. Clonal hematopoiesis of indeterminate potential is associated with heart failure with preserved ejection fraction in humans.

    “Recent studies demonstrate that CHIP is enriched in HFpEF populations and is associated with increased disease risk and worse clinical outcomes.”

    Review

    Clonal Hematopoiesis and Inflammatory Pathways in Heart Failure with Preserved Ejection Fraction

    Current heart failure reports

More on Clonal hematopoiesis of indeterminate potential

Inflammation

upin humans1upin reviews1

2 studies
  1. Inflammation is associated with heart failure with preserved ejection fraction in humans.

    “A comorbidity-driven systemic proinflammatory state, together with coronary microvascular endothelial inflammation, has emerged as a central paradigm in HFpEF pathogenesis.”

    Review

    Inflammation, metabolism, and aging in heart failure with preserved ejection fraction: Mechanisms and treatment perspectives

    Journal of translational internal medicine

  2. Inflammation is associated with heart failure with preserved ejection fraction.

    “inflammaging, a chronic, low-grade inflammatory state driven by immunosenescence, mitochondrial dysfunction, and cellular senescence, to progressive myocardial fibrosis, diastolic stiffness, and HFpEF development.”

    Reviewheart

    HFpEF, Aging, Inflammaging, and the Future of Anti-Inflammatory: Therapy in Heart Failure with Preserved Ejection Fraction

    Aging and disease

More on Inflammation

Change in Kansas City Cardiomyopathy Questionnaire overall summary score

upin humans1

1 study
  1. Heart failure with preserved ejection fraction is associated with change in Kansas City Cardiomyopathy Questionnaire overall summary score in humans (Compared with heart failure with reduced ejection fraction).

    “the change over time differed significantly between HF types (p for time*HF type=0.005), with a greater improvement observed in HFpEF.”

    Human trialCompared with heart failure with reduced ejection fraction1 yearn = 337

    Impact of different exercise training modalities on patient-reported outcomes in heart failure with reduced and preserved ejection fraction

    ESC Congress 2026 abstract

All 109

Trial sponsors

Latest

Dec 2025: 20Jan 2026: 37Feb 2026: 50Mar 2026: 52Apr 2026: 11May 2026: 16Jun 2026: 15Jul 2026: 23Aug 2026: 29Sep 2026: 42Oct 2026: 108Nov 2026: 78481 papers in 12 months
Environmental Science & Technology

Fine-particle pollution linked to heart failure types in China

A prospective cohort followed 101,521 Chinese adults for a median 14.83 years, linking different pollution components to different heart failure subtypes.A prospective cohort followed 101,521 Chinese adults for a median 14.83 years, linking different pollution components to different heart failure subtypes.

Cohort · 101,521 peopleHeart failure
bioRxiv

Loss of nuclear support proteins harms mouse hearts and arteries

Median survival was 14.6% lower in artery-disease-prone mice lacking the proteins in blood-vessel-lining cells than in comparison mice.Median survival was 14.6% lower in artery-disease-prone mice lacking the proteins in blood-vessel-lining cells than in comparison mice.

Preprint: mouse studyMechanisms

See all 894 papers on heart failure with preserved ejection fraction